Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Dabigatran[1] Dabigatran[1] Dabigatran 💬 [1] F2 💬 [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬[3] 85, 91, 124 💬
2Rivaroxaban[1] Rivaroxaban[1] Rivaroxaban 💬 [1] F10 💬 [1] Complement and coagulation cascades 💬[5] 46, 49, 91, 210, 271 💬
3Rivaroxaban 20 MG[1] Rivaroxaban[1] Rivaroxaban 💬 [1] F10 💬 [1] Complement and coagulation cascades 💬[1] 91 💬
4Warfarin[1] Warfarin[3] Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬
[2] NQO1,
VKORC1 💬
[5] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬[10] 6, 8, 19, 46, 49, 66, 85, 86, 88, 91 💬